Its patient-friendly dosing schedule makes it a convenient daily choice
weight-loss pharmacotherapy may not be appropriate Gastrointestinal conditions, particularly gastroparesis or inflammatory bowel disease Thyroid disorders (report any symptoms such as neck swelling, difficulty swallowing, or hoarseness) Diabetes and current glycaemic control Cardiovascular conditions Any history of pancreatitis or gallbladder disease All current medications and supplements must be disclosed, as both Wegovy and escitalopram may interact with other medicines
Not everyone responds to medications the same way, and retatrutide is still being studied in clinical trials
Hours of online training videos & FREE post training follow up and support Downloadable Training Resources: Guidebooks, Sample Patient Forms, and Essential Articles A Certificate of Completion in Medical Weight Loss Training Join our Mastermind and receive FREE mentorship
EP2866825, on the use of semaglutide in specific dosage regimens and formulations for the treatment of obesity and Type 2 diabetes
